论文部分内容阅读
骨质疏松及其伴随的骨量减少,是公认的重大公共卫生问题。在口腔医学领域骨质疏松加剧了颌骨的骨折和牙槽骨吸收萎缩的风险,不仅影响美观,发音和咀嚼功能,还严重影响患者的身心健康。骨质疏松最严重的结果是骨折,美国罗彻斯特流行病学项目显示骨折的发病率在近20年仍在持续增加[1]。学者们对骨质疏松的治疗一直进行探索,他们从不同角度探讨一些药物对骨质疏松治疗效果,但因其治疗过程中存在的副作用又限制了其临床应
Osteoporosis and its attendant osteopenia are recognized as major public health problems. Osteoporosis in the field of stomatology aggravates the risk of jaw fractures and alveolar bone atrophy, which not only affects aesthetics, pronunciation and masticatory function, but also seriously affects the patient’s physical and mental health. The most serious result of osteoporosis is fractures. The Rochester Epidemiology Program shows that the incidence of fractures continues to increase in the past two decades [1]. Scholars have been exploring the treatment of osteoporosis, they explore the effect of some drugs on the treatment of osteoporosis from different angles, but because of the side effects of its treatment also limits its clinical